Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC).
D. Ross Camidge
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Sai-Hong Ignatius Ou
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Geoffrey Shapiro
Research Funding - Pfizer
Gregory Alan Otterson
Research Funding - Pfizer
Liza Cosca Villaruz
No relevant relationships to disclose
Miguel Angel Villalona-Calero
No relevant relationships to disclose
A. John Iafrate
Consultant or Advisory Role - Pfizer
Marileila Varella-Garcia
Research Funding - Merck Serono
Sanja Dacic
No relevant relationships to disclose
Stephanie Cardarella
No relevant relationships to disclose
Weiqiang Zhao
No relevant relationships to disclose
Lesley Tye
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Patricia Stephenson
Consultant or Advisory Role - Pfizer
Keith D. Wilner
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Leonard Philip James
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Other Remuneration - Pfizer
Mark A. Socinski
Research Funding - Pfizer